Acute insulin response and beta-cell compensation in normal subjects treated with olanzapine or risperidone for 2 weeks: response to Hardy et al.
Jindal
Ripu D
RD
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001569:Benzodiazepines / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007328:Insulin / Q000096:biosynthesis; D007333:Insulin Resistance / Q000502:physiology; D050417:Insulin-Secreting Cells / Q000187:drug effects*; D000077152:Olanzapine; D018967:Risperidone / Q000494:pharmacology*
D014150:Antipsychotic Agents; D007328:Insulin; D001569:Benzodiazepines; D018967:Risperidone; D000077152:Olanzapine